Valencia, CA – According to filings with the U.S. Securities and Exchange Commission, SetPoint Medical is raising $64,407,963.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Murthy Simhambhatla played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About SetPoint Medical

SetPoint Medical, headquartered in Valencia, Ca., is a privately-held clinical-stage bioelectronic medicine company dedicated to treating patients with chronic autoimmune diseases. The company is pioneering a new treatment paradigm, using electrical pulses that activate the body’s innate Inflammatory Reflex, for rheumatoid arthritis, Crohn’s disease and other chronic autoimmune diseases as a safe, cost-effective alternative to drugs and biologics.

To learn more about SetPoint Medical, visit http://www.setpointmedical.com/

Contact:
Murthy Simhambhatla, President and Chief Executive Officer
661-750-6140
msimhambhatla@setpointmedical.com
https://www.linkedin.com/in/murthy-simhambhatla-884668bb/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved